Innate and adaptive immune responses to SARS‐CoV‐2 in humans: relevance to acquired immunity and vaccine responses

Human leukocyte antigen susceptibility map for SARS-CoV-2

(2020) Austin Nguyen et al.   JOURNAL OF VIROLOGY

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

(2020) Cynthia Magro et al.   Translational Research

Interleukin 6

(2020) Stanley C. Jordan et al.   TRANSPLANTATION

In‐depth virological assessment of kidney transplant recipients with COVID‐19

(2020) Ilies Benotmane et al.   AMERICAN JOURNAL OF TRANSPLANTATION

C1 esterase inhibitor and the contact system in COVID‐19

(2020) Timothy M. Thomson et al.   BRITISH JOURNAL OF HAEMATOLOGY

Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized COVID-19 Patients

(2020) Christina C. Price et al.   CHEST

Tocilizumab for treatment of mechanically ventilated patients with COVID-19

(2020) Emily C Somers et al.   CLINICAL INFECTIOUS DISEASES

Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia

(2020) Stanley C Jordan et al.   CLINICAL INFECTIOUS DISEASES

Lessons for COVID-19 Immunity from Other Coronavirus Infections

(2020) Alan Sariol et al.   IMMUNITY

A role for human leucocyte antigens in the susceptibility to SARS‐Cov‐2 infection observed in transplant patients

(2020) Kay Poulton et al.   International Journal of Immunogenetics

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

(2020) Julian Braun et al.   NATURE

Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis

(2020) Julien Carvelli et al.   NATURE

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

(2020) Nina Le Bert et al.   NATURE

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

(2020) Davide F. Robbiani et al.   NATURE

Single-cell landscape of immunological responses in patients with COVID-19

(2020) Ji-Yuan Zhang et al.   NATURE IMMUNOLOGY

Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection

(2020) Vijendra Ramlall et al.   NATURE MEDICINE

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

(2020) F. Javier Ibarrondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

(2020) Jose Mateus et al.   SCIENCE

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19

(2020) Mark Roschewski et al.   Science Immunology

COVID-19 and the Path to Immunity

(2020) David S. Stephens et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies

(2020) Christopher O. Barnes et al.   NATURE

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

(2020) Yanchun Peng et al.   NATURE IMMUNOLOGY

T cells in COVID-19 — united in diversity

(2020) Leo Swadling et al.   NATURE IMMUNOLOGY

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

(2020) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 in children and young people

(2020) Matthew D. Snape et al.   SCIENCE

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System

(2020) Pascal Urwyler et al.   Frontiers in Immunology

COVID-19: Infection or Autoimmunity

(2020) Timothy Icenogle   Frontiers in Immunology

Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer

(2020) Teresa Aydillo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Covid-19: Critically ill patients treated with arthritis drug tocilizumab show improved outcomes, researchers report

(2020) Jacqui Wise   BMJ-British Medical Journal

Examining coagulation-complement crosstalk: complement activation and thrombosis

(2016) Jonathan H. Foley   THROMBOSIS RESEARCH

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

(2008) Xiaocong Yu et al.   NATURE